YW3-56 (hydrochloride) (technical grade)

A PAD2 and PAD4 inhibitor

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
500ug

￥2037.00

1630.00

- +
1mg

￥3862.00

3090.00

- +
5mg

￥13087.00

10470.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

YW3-56 is an inhibitor of protein arginine deiminase 2 (PAD2) and PAD4 (IC₅₀s = 0.5-1 and 1-5 μM, respectively).¹ It inhibits the growth of U2OS osteosarcoma cells (IC₅₀ = ~2.5 μM) in a p53-dependent manner via induction of SESN2 and subsequent inhibition of mTORC1. YW3-56 (10 mg/kg) reduces tumor growth in an S-180 murine sarcoma tumor model. It also inhibits tumor growth in the 1883 MDA-MB-231 breast cancer bone metastasis mouse xenograft model.²

1.Wang, Y., Li, P., Wang, S., et al.Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activityThe Journal of Biological Chemisty287(31)25941-25952(2012) 2.Wang, S., Chen, X.A., Hu, J., et al.ATF4 gene network mediates cellular response to the anticancer PAD inhibitor YW3-56 in triple-negative breast cancer cellsMol. Cancer Ther.14(4)877-888(2015)